title: A multiple dose powder inhaler (Turbuhaler) compared with a conventional aerosol. An acceptance study in asthmatics.
abstract: Nineteen patients with asthma completed an open, randomized, crossover study in which 0.5 mg terbutaline sulphate was administered either via Turbuhaler or via the metered dose inhaler (MDI) for 2-week periods. The clinical effect of the two treatment forms was comparable; both provided adequate bronchodilator therapy. Patients also considered Turbuhaler and MDI equally effective, with a small preference for the MDI. Turbuhaler seems to be a valuable alternative to bronchodilator MDI therapy.
authors.affiliation: Dept. of Lung Medicine, Karolinska Sjukhuset, Stockholm, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Osterman
authors.forename: A M
authors.initials: AM
authors.lastname: Norborg
authors.forename: E
authors.initials: E
authors.lastname: Stähl
mesh_terms: D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D003258:Consumer Behavior; D004867:Equipment Design; D005260:Female; D006801:Humans; D008168:Lung / Q000502:physiology; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D011208:Powders; D011897:Random Allocation; D013726:Terbutaline / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000336:Aerosols; D011208:Powders; D013726:Terbutaline